Offer - Urjas Oil for just ₹ 1 X
Remipex 0.25 Tablet, a prescription drug, is manufactured in various forms such as Tablet. It is primarily used for the treatment of Parkinson's Disease. The alternative uses of Remipex 0.25 Tablet have also been explained below.
The right dosage of Remipex 0.25 Tablet depends on the age, gender, and medical history of the patient. Besides the medical condition it is advised for, the route of administration also plays an important role in determining the correct drug dosage. Refer to the dosage section for a detailed discussion.
While these are the most often observed Remipex 0.25 Tablet side effects, there are can be others also. These have been listed below. These side effects of Remipex 0.25 Tablet are usually temporary and subside with the completion of treatment. However, if these continue for a longer time, consult your doctor right away.
It is also important to note that Remipex 0.25 Tablet has a Moderate effect for pregnant women and Severe effect on lactating mothers. It is important to know if Remipex 0.25 Tablet has any effect on the kidney, liver and heart. Information on such adverse effects, if any, has been given in the Remipex 0.25 Tablet related warnings section.
Individuals suffering from medical conditions like Schizophrenia, Heart Disease, Kidney Disease must refrain from the use of Remipex 0.25 Tablet since this can cause severe adverse effects.
Besides this, Remipex 0.25 Tablet may also have severe interaction with some medicines. See below for a complete list.
In addition to these precautions, you may also note that Remipex 0.25 Tablet is not safe while driving, and is is not addictive in nature.
Remipex 0.25 Tablet is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
Is the use of Remipex 0.25 Tablet safe for pregnant women?
Remipex can have harmful effects in pregnant women. If you experience any discomfort after using Remipex, then discontinue the use and take your doctor's advice.
Is the use of Remipex 0.25 Tablet safe during breastfeeding?
Taking Remipex may lead to serious side effects if you are breastfeeding. Remipex should not be taken by breastfeeding women unless prescribed by the doctor.
What is the effect of Remipex 0.25 Tablet on the Kidneys?
Remipex rarely harms the kidneys.
What is the effect of Remipex 0.25 Tablet on the Liver?
Remipex is not harmful for the liver.
What is the effect of Remipex 0.25 Tablet on the Heart?
Remipex may have mild side effects on the heart. Most people will never see any effect on the heart.
If you are suffering from any of the following diseases, you should not take Remipex 0.25 Tablet unless your doctor advises you to do so -
Is this Remipex 0.25 Tablet habit forming or addictive?
No, you will not get addicted to Remipex 0.25 Tablet.
Is it safe to drive or operate heavy machinery when consuming?
You may feel sleepy or tired after taking Remipex 0.25 Tablet. So it is best to avoid driving.
Is it safe?
Remipex 0.25 Tablet is safe but it is important to consult a doctor before taking it.
Is it able to treat mental disorders?
Yes, Remipex 0.25 Tablet is useful in treating mental disorders.
Interaction between Food and Remipex 0.25 Tablet
Remipex 0.25 Tablet may take longer to act if you eat some foods while taking it. Follow your doctor's advice on this.
Interaction between Alcohol and Remipex 0.25 Tablet
Taking Remipex 0.25 Tablet with alcohol can have severely harmful effects on your health.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Mirapex® (pramipexole dihydrochloride)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1043-1044
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 430-431